Home ›
Trademark Categories ›
Pharmaceuticals ›
2005 ›
PH ›
PHARMACRYST
Trademark search for:
PHARMACRYST
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2005-12-27 — Application filed
2006-01-04 — Application filed
2006-06-22 — Final disposition recorded
2006-06-22 — Final disposition recorded
2006-06-22 — Assigned to examiner
2006-12-12 — Paper received
2007-01-16 — Suspension letter written
2007-01-16 — Letter of suspension e-mailed
2007-01-16 — Amendment from applicant entered
2007-01-16 — Assigned to lie
2007-01-16 — Correspondence received in law office
2007-07-16 — Suspension inquiry written
2007-07-16 — Inquiry to suspension e-mailed
2007-07-16 — Notification of inquiry as to suspension e-mailed
2008-01-10 — Paper received
2008-01-14 — Assigned to lie
2008-01-16 — Suspension letter written
2008-01-16 — Letter of suspension e-mailed
2008-01-16 — Notification of letter of suspension e-mailed
2008-01-16 — Amendment from applicant entered
2008-01-16 — Correspondence received in law office
2008-07-17 — Suspension inquiry written
2008-07-17 — Inquiry to suspension e-mailed
2008-07-17 — Notification of inquiry as to suspension e-mailed
2009-02-12 — Application abandoned
2009-02-12 — Application abandoned
2009-02-26 — Office action issued
2009-02-26 — Petition to revive-granted
2009-02-26 — Teas petition to revive received
2009-02-27 — Suspension letter written
2009-02-27 — Letter of suspension e-mailed
2009-02-27 — Notification of letter of suspension e-mailed
2009-02-27 — Teas/email correspondence entered
2009-02-27 — Correspondence received in law office
2009-08-27 — Suspension inquiry written
2009-08-27 — Inquiry to suspension e-mailed
2009-08-27 — Notification of inquiry as to suspension e-mailed
2009-08-27 — Suspension checked - to attorney for action
2010-01-04 — Assigned to examiner
2010-02-03 — Automatic update of assignment of ownership
2010-02-26 — Attorney/dom.rep.revoked and/or appointed
2010-02-26 — Suspension letter written
2010-02-26 — Letter of suspension e-mailed
2010-02-26 — Notification of letter of suspension e-mailed
2010-02-26 — Teas revoke/app/change addr of atty/dom rep received
2010-08-26 — Suspension inquiry written
2010-08-26 — Inquiry to suspension e-mailed
2010-08-26 — Notification of inquiry as to suspension e-mailed
2010-08-26 — Teas change of correspondence received
2010-10-13 — Assigned to examiner
2011-02-28 — Teas response to suspension inquiry received
2011-02-28 — Correspondence received in law office
2011-03-01 — Teas/email correspondence entered
2011-03-10 — Approved for pub - principal register
2011-03-26 — Assigned to lie
2011-03-26 — Law office publication review completed
2011-05-03 — Published for opposition
2011-05-03 — Official gazette publication confirmation e-mailed
2011-06-28 — Noa e-mailed - sou required from applicant
2012-01-30 — Application abandoned
2012-01-30 — Application abandoned
2012-01-30 — Final status recorded
Owner Information
SMITH & NEPHEW (OVERSEAS) LIMITED
LONDON GB
SMITH & NEPHEW (OVERSEAS) LIMITED
LONDON GB
Nucryst Pharmaceuticals Corp.
Fort Saskatchewan, Alberta CA
Correspondent
CHRISTOPHER P. BUSSERT KILPATRICK STOCKTON LLP 1100 PEACHTREE ST NE STE 2800 ATLANTA, GA 30309-4530
Filing Details
Filing Date:
2005-12-27
Status Date:
2012-01-30
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.